Anti‐hypertensive use for non‐severe gestational hypertension in Botswana: A case‐control study

The fetal risks and benefits of antihypertensives to treat gestational hypertension in pregnancy are understudied, particularly in low‐ and middle‐income countries. Cases with SGA were more likely to have used an anti‐hypertensive than controls (33% vs 29%, adjusted odds ratio [aOR] 1.28, 95% confidence interval [CI] 1.15–1.43). Cases with stillbirth were more likely to have used an anti‐hypertensive than controls (42% versus 29%, aOR 1.45, 95% CI 1.14–1.83). Anti‐hypertensive use for new‐onset gestational hypertension was associated with an increased risk of having an SGA infant or a stillbirth among women who never developed severe hypertension.